New site coming soon
FROM SCIENCE TO BUSINESS
Key Elements
A full day dedicated to innovation in health and biomedical research.
A unique platform connecting academia, startups, companies, and public institutions.
Great visibility for sponsors and partners.
A well-structured agenda with plenary sessions, keynotes, and B2B meetings
What CID offers
A unique matchmaking environment between public and private players.
Visibility and recognition for over 30 top-tier French research cohorts.
A national dynamic supporting translational research.
An effective communication tool for funders, industry and labs
2025 Priority Themes
Prevention and Public Health
Artificial Intelligence and Health Data
Translational Research and Innovative Clinical Trials
Personalized Medicine and Patient Pathways
More than 30 French excellence cohorts
CID showcases over 30 nationally recognized French cohorts in fields such as cardiometabolic, neurology, infectious diseases, oncology, and more.
Each cohort will present its results, challenges, and opportunities for collaborations
Provisional Program – Cohort Innovation Day 2025
Morning:
Plenary Sessions & Round Tables
08:30 – 09:00: Opening remarks
Speakers: Marc, Christian (INSERM)
09:00 – 10:00: First Round Table – Public-Private Partnerships (PPP)
Moderator to be confirmed
10:00 – 10:45: Presentation of scientific projects from 3 cohorts
Moderator to be confirmed
10:45 – 11:00: Coffee break
11:00 – 12:00: Second Round Table – Topic to be confirmed
Moderator to be confirmed
12:00 – 12:30: Presentation of scientific projects from 2 cohorts
Moderator to be confirmed
12:30 – 12:45: Sponsor keynote or intervention
Speaker to be confirmed
12:45 – 13:15: European Keynote
Lunch:
13:30 – 14:00: Lunch break
Afternoon: B2B Meetings
15 tables – 8 slots – up to 120 meetings possible
Be the first to join — pre-register now for the 2025 edition of Cohort Innovation Day!
Stay up-to-date with the latest news on CID, register here
Sponsorship – Why Support CID 2025?
Becoming a sponsor of Cohort Innovation Day 2025 means positioning your organization at the heart of cutting-edge biomedical research and innovation.
Support the event, gain visibility among key players in health research, and help foster collaborations between public cohorts and private stakeholders.
Download the sponsorship brochure to explore all our partnership opportunities and pricing details.
- Details
- Written by Super User
- Category: Info
Provisional schedule:
October 3rd, 2018 – Paris
| 9:00 am - 9:10 am |
Opening remarks: why France? - Yves LEVY, Chairman of Aviesan & Marc BONNEVILLE, Chairman of ARIIS |
| 9:10 am - 9:30 am |
21st century epidemiology: challenges and opportunities - Gilles BABINET, France’s Digital Champion for the European Commission |
| 9:30 am - 9:50 am |
The "Constances" cohort: design, applications and foresight - Marie ZINS, Scientific leader of Constances |
| 9:50 am - 10:45 am |
Round table 1 - AI for biomarker discovery: what can we truly expect ? - Stanley DURRLEMAN, Researcher, Inria & ICM Brain and Spine Institute - Xosé FERNANDEZ, Chief Data Officer, Curie Institute - Meriem SEFTA, Partnership and Translational Research Manager, Owkin - Benoit TYL, Director of Cardiovascular Translational Research, Servier - Nicolas VILLAIN, Head of Research in AI for Medical Imaging, Philips |
| 10:45 am - 11:00 am |
Practical case - From Paris to Boston: a "deep patient" in nephrology - Alexandre LOUPY, Nephrologist at the Department of Nephrology and Kidney Transplantation, Necker Hospital |
| 11:00 am - 11:30 am |
Coffee break - Networking |
| 11:30 am - 11:50 am |
An insight by a global industry - Human derived genome scale data sets and advances analytics to accelerate drug discovery - Philippe SANSEAU, Head of Computational Biology and Stats, GSK |
| 11:50 am - 12:45 am |
Round table 2 - Real-world data: a broad foresight on this tomorrows' gold standard - Michèle ARNOE, Head Growth and Innovation, IQVIA - Valérie EDEL, Vice-Director, Health data Institute - Marc FROUIN, Chief Operating Officer, BioSerenity - Ramon HERNANDEZ, Head of Advanced Analytics in R&D, Sanofi - Remy SLAMA, Scientific coordinator of the SEPAGES cohort (to be confirmed) |
| 12:45 am - 12:55 pm |
Overview of the rising French start-ups using AI on cohorts - Rosalie MAURISSE, Head of the health sector, Expertise Direction, BpiFrance |
| 12:55 pm - 1:15 pm |
Concluding remarks and insight from Israel - Ran BALICER, Founding Director, Clalit Research Institute of Israel
|
| 1:15 pm - 2:30 pm |
Lunch & Networking with start-ups [PRIVATE ACCESS - by invitation only] |
| 2:30 pm - 6:00 pm |
B2B meetings [PRIVATE ACCESS - by invitation only] |
- Details
- Written by Super User
- Category: Info
Organizing committee
Zeina ANTOUN, GSK
Vanessa BESSON-DUBOURG, INSERM TRANSFERT
Alice BOUSSELET, INSERM TRANSFERT
Mireille CARALP, INSERM TRANSFERT
Aurélie DEFAUX, ARIIS
Sylvain DURRLEMAN, Aviesan/ITMO Santé Publique
Marco FIORINI, ARIIS
Véronique FOUINAT, ARIIS
Jean-Marie GAGLIOLO, Aviesan/ITMO Santé Publique
Anne HAZIZA, ARIIS
Industrials members of steering committee
BATAMAN-ONAL Yasemin, Sanofi Pasteur
BEZIZ Dan, Lilly
CHEVALIER Marie-Pierre, Pfizer
DELONCA Jean, Shire
DUBOIS Frédéric, Servier
FAUCONNIER Laurence, Stago
JULLIAN Nathalie, Ipsen
LESAGE Sabrina, Pfizer
LONGIN Juliette, Merck
NACHBAUR Gaëlle, GSK
PETIT-NIVARD Jean-Frédéric, Roche
SALZMAN Valérie, Servier
THEVENON Julien, Janssen France / Johnson & Johnson
THOMAS-DELECOURT Florence, AstraZeneca
TIREL Anny, MSD
